Blueprint
 
FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending 03 May 2018
 
GlaxoSmithKline plc
(Name of registrant)

 
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)

 
 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F

 
 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.

 
 
 
Yes      No x
 
 
 
 
 
 
 
 
 GlaxoSmithKline plc
 
Result of Annual General Meeting
 
GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') today, all resolutions were passed by shareholders. The full text of each resolution is contained in the 2018 Notice of AGM which is available on the GSK website at www.gsk.com. 
 
GSK AGM Poll Results
 
The following table shows the total number of votes cast for each resolution:
 
 
Resolution
Total votes for*
%
Total votes against
%
Total votes cast
Votes withheld**
1
Receive and adopt the 2017 Annual Report
3,774,060,035
96.85
122,642,168
3.15
3,896,702,203
9,102,585
2
Approve the Annual report on remuneration
2,851,170,418
90.41
302,423,307
9.59
3,153,593,725
752,204,847
3
Election of Dr Hal Barron
3,881,663,314
99.53
18,181,557
0.47
3,899,844,871
5,937,889
4
Election of Dr Laurie Glimcher
3,886,364,801
99.64
13,925,416
0.36
3,900,290,217
5,484,445
5
Re-election of Philip Hampton
3,880,514,761
99.49
19,714,243
0.51
3,900,229,004
5,551,448
6
Re-election of Emma Walmsley
3,885,288,493
99.61
15,236,656
0.39
3,900,525,149
5,261,280
7
Re-election of Vindi Banga
3,874,981,084
99.37
24,610,295
0.63
3,899,591,379
6,184,729
8
Re-election of Dr Vivienne Cox
3,784,417,872
97.05
114,935,231
2.95
3,899,353,103
6,421,540
9
Re-election of Simon Dingemans
3,826,327,989
98.12
73,437,843
1.88
3,899,765,832
6,009,962
10
Re-election of Lynn Elsenhans
3,877,253,828
99.41
23,041,318
0.59
3,900,295,146
5,478,806
11
Re-election of Dr Jesse Goodman
3,886,003,347
99.63
14,266,676
0.37
3,900,270,023
5,506,284
12
Re-election of Judy Lewent
3,794,070,532
97.29
105,710,801
2.71
3,899,781,333
5,994,672
13
Re-election of Urs Rohner
3,871,948,993
99.29
27,625,403
0.71
3,899,574,396
6,201,911
14
Appointment of Deloitte LLP as the auditors
3,892,781,525
99.79
8,074,204
0.21
3,900,855,729
4,930,709
15
Remuneration of auditors
3,889,076,112
99.71
11,291,626
0.29
3,900,367,738
5,413,277
16
Authority for the company to make donations to political organisations and incur political expenditure
3,814,639,515
97.86
83,559,851
2.14
3,898,199,366
7,600,333
17
Authority to allot shares
3,749,621,504
96.23
147,032,649
3.77
3,896,654,153
9,128,625
18
Disapplication of pre-emption rights - general power***
3,792,164,960
97.38
101,981,885
2.62
3,894,146,845
11,614,736
19
Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment***
3,675,122,062
94.36
219,534,966
5.64
3,894,657,028
11,110,220
20
Authority for the company to purchase its own shares***
3,834,088,739
98.40
62,147,383
1.60
3,896,236,122
9,555,694
21
Exemption from statement of senior statutory auditor's name
3,864,323,350
99.16
32,625,496
0.84
3,896,948,846
8,825,695
22
Authority for reduced notice of a general meeting other than an AGM***
3,641,775,376
93.45
255,347,155
6.55
3,897,122,531
8,662,254
23
Approve the adoption of new Articles of Association***
3,883,973,088
99.79
8,108,271
0.21
3,892,081,359
11,790,307
 
Notes:
 
*
 
Includes discretionary votes.
 
**
 
A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
 
***
 
Indicates Special Resolutions requiring a 75% majority.
 
 
The above poll results will shortly be available on the company's website at www.gsk.com.
 
In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM
 
Professor Sir Roy Anderson did not stand for re-election as a Director and retired from the Board with effect from the conclusion of the AGM.
 
In accordance with section 430(2B) of the Companies Act 2006, GSK confirms that Professor Sir Roy Anderson will receive payment of fees for service whilst a Director but no other remuneration payment or payment for loss of office will be made in connection with his departure.
 
The following table provides further relevant information:
 
 
 
GSK's
Eighteen
AGM
(2018)
 
GSK's
Seventeenth
AGM
(2017)
Issued share capital (excluding Treasury Shares)
4,959,302,644
4,917,502,476
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
78.76%
74.43%
Total shareholder population
112,326
116,502
Total number of proxies lodged
6,931
7,336
% of shareholders who lodged proxies
6.17%
6.30%
Number of shareholders, corporate representatives and proxies who attended the AGM
415
435
 
 
 
V A Whyte
Company Secretary
3 May 2018
 
 
 
 
 
 
 
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 
 
GlaxoSmithKline plc
 
(Registrant)
 
 
Date: May 03,2018 
 
 
 
 
By: VICTORIA WHYTE
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GlaxoSmithKline plc